Literature DB >> 23653236

Diagnostic accuracy of preoperative alpha-fetoprotein as an ovarian tumor marker in children and adolescents: not as good as we thought?

Amos Hong Pheng Loh1, Kelvin Wai Cheak Gee, Joyce Horng Yiing Chua.   

Abstract

PURPOSE: To evaluate the diagnostic accuracy of preoperative serum alpha-fetoprotein (AFP) levels in predicting malignancy risk in children and adolescents presenting with ovarian neoplasms.
METHODS: In 110 girls aged 18 and below diagnosed with ovarian neoplasms, we retrospectively correlated preoperative serum AFP levels with histological diagnosis of germ cell tumor or immature teratoma (GCT/IT) versus non-GCT/IT, and benign versus non-benign. We determined area under receiver-operating characteristic curves (AUC), sensitivity, specificity, and likelihood ratios.
RESULTS: Twenty patients (18.2 %) had non-benign ovarian neoplasms, of which 12 had GCT/IT (10.9 %). In diagnosing GCT/IT versus non-GCT/IT, specificity of preoperative serum AFP was 87.8 %, sensitivity 66.7 %, and AUC 0.853. Excluding infants to remove the effects of increased variance in AFP in this group, specificity improved (92.0 %), but not sensitivity (66.7 %); AUC was 0.926. Increasing AFP cutoff to two times upper normal limit improved specificity (94.9 %), but not sensitivity (66.7 %). For benign versus non-benign tumors, AFP specificity was only 88.9 % and sensitivity 50.0 %.
CONCLUSION: The diagnostic accuracy of preoperative serum AFP for detecting GCT/IT in girls was limited by poor sensitivity and positive predictive value. Excluding infants and raising cutoff levels improved specificity marginally. Clinicians should be aware of these limitations when using AFP in the preoperative evaluation of childhood ovarian neoplasms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23653236     DOI: 10.1007/s00383-013-3316-6

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  30 in total

Review 1.  Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.

Authors:  D T Schneider; G Calaminus; U Göbel
Journal:  Pediatr Hematol Oncol       Date:  2001 Jan-Feb       Impact factor: 1.969

2.  Carcinoembryonic antigen and alpha fetoprotein levels in retinoblastoma.

Authors:  M Minei; Y Yamana; Y Ohnishi
Journal:  Jpn J Ophthalmol       Date:  1983       Impact factor: 2.447

3.  Three different types of alpha-fetoprotein in the diagnosis of malignant solid tumors: use of a sensitive lectin-affinity immunoelectrophoresis.

Authors:  Y Tsuchida; M Kaneko; M Fukui; H Sakaguchi; T Ishiguro
Journal:  J Pediatr Surg       Date:  1989-04       Impact factor: 2.545

4.  Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group.

Authors:  S A Heifetz; B Cushing; R Giller; J J Shuster; C J Stolar; C D Vinocur; E P Hawkins
Journal:  Am J Surg Pathol       Date:  1998-09       Impact factor: 6.394

5.  Pediatric risk of malignancy index for preoperative evaluation of childhood ovarian tumors.

Authors:  Amos Hong Pheng Loh; Chiou Li Ong; Shu Lin Lam; Joyce Horng Yiing Chua; Chan Hon Chui
Journal:  Pediatr Surg Int       Date:  2011-12-08       Impact factor: 1.827

6.  Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study.

Authors:  N M Marina; B Cushing; R Giller; L Cohen; S J Lauer; A Ablin; R Weetman; J Cullen; P Rogers; C Vinocur; C Stolar; F Rescorla; E Hawkins; S Heifetz; P V Rao; M Krailo; R P Castleberry
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

7.  Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.

Authors:  E E Mooney; F F Nogales; F A Tavassoli
Journal:  Hum Pathol       Date:  1999-06       Impact factor: 3.466

Review 8.  Epithelial ovarian tumors in children: a retrospective analysis.

Authors:  Michael Morowitz; Dale Huff; Daniel von Allmen
Journal:  J Pediatr Surg       Date:  2003-03       Impact factor: 2.545

9.  Can we preoperatively risk stratify ovarian masses for malignancy?

Authors:  Sarah C Oltmann; Nilda Garcia; Robert Barber; Rong Huang; Barry Hicks; Anne Fischer
Journal:  J Pediatr Surg       Date:  2010-01       Impact factor: 2.545

10.  Malignant ovarian tumours in childhood in Britain, 1962-78.

Authors:  C La Vecchia; H B Morris; G J Draper
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

View more
  3 in total

Review 1.  Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.

Authors:  Mariana Horta; Teresa Margarida Cunha; Rita Canas Marques; Ana Félix
Journal:  J Radiol Case Rep       Date:  2014-11-30

2.  Selecting treatment method for ovarian masses in children - 24 years of experience.

Authors:  Justyna Łuczak; Maciej Bagłaj
Journal:  J Ovarian Res       Date:  2017-09-11       Impact factor: 4.234

3.  Management of pediatric benign ovarian tumors in England and Egypt: A comparative study.

Authors:  Ahmed Elgendy; Bhanumathi Lakshminarayanan; Ahmed Elrouby; Mahmoud Mostafa; Mohamed Abouelmagd Salem; Kerry Turner; Ahmed Khairi; Roly Squire; Sherif M K Shehata; Sameh Shehata; Mark Powis
Journal:  Afr J Paediatr Surg       Date:  2020 Jan-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.